Cookson Peirce & Co’s Elevance Health ELV Stock Holding History

Cookson Peirce & Co’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-39,042	Closed	-$18M	–	227
2023 Q1	$18M	Buy	39,042 +354	+0.9%	+$168K	1.15%	31
2022 Q4	$19.8M	Buy	38,688 +403	+1%	+$205K	1.29%	31
2022 Q3	$17.4M	Buy	38,285 +784	+2%	+$375K	1.23%	34
2022 Q2	$18.1M	Buy	37,501 +106	+0.3%	+$52.4K	1.25%	33
2022 Q1	$18.4M	Buy	+37,395	New	+$17.1M	1.07%	39
2015 Q4	–	Sell	-25,475	Closed	-$3.57M	–	141
2015 Q3	$3.57M	Sell	25,475 -44,710	-64%	-$6.72M	0.59%	53
2015 Q2	$11.5M	Sell	70,185 -3,960	-5%	-$633K	1.92%	20
2015 Q1	$11.4M	Buy	74,145 +23,770	+47%	+$3.38M	2%	19
2014 Q4	$6.33M	Buy	50,375 +550	+1%	+$68K	1.31%	28
2014 Q3	$5.96M	Buy	49,825 +23,945	+93%	+$2.75M	1.39%	28
2014 Q2	$2.79M	Buy	+25,880	New	+$2.67M	0.67%	48

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cookson Peirce & Co's ELV Position: Q2 2023 in Review

Cookson Peirce & Co sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 39,042 shares — an estimated $18M sold.

Cookson Peirce & Co first reported a position in ELV in Q2 2014 and held it in 11 quarters. The position peaked at $19.8M in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

Cookson Peirce & Co reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
Cookson Peirce & Co sold 39,042 Elevance Health shares in Q2 2023, an estimated $18M.
Cookson Peirce & Co first reported a position in Elevance Health in Q2 2014 and held it in 11 quarters.
Cookson Peirce & Co's Elevance Health position peaked at $19.8M in Q4 2022.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Cookson Peirce & Co's 13F filing for Q2 2023, filed 1 Aug 2023.